Rich Gelfond, the CEO of IMAX, recently expressed an optimistic forecast for the company’s future at the box office, suggesting that 2025 could see revenues soar to a staggering $1.2 billion. This potential would signify a new milestone for IMAX, a pioneer in high-resolution viewing experiences known for its advanced cameras, unique film formats, and
Business
After a protracted struggle with supply issues, the United States Food and Drug Administration (FDA) has announced that the shortage of Novo Nordisk’s weight loss injection, Wegovy, and the diabetes treatment, Ozempic, has come to an end. This announcement comes after more than two years of rising demand and escalating supply challenges. The resolution of
For the first time in five decades, the New York Yankees have made a significant shift in their grooming policy by permitting players to grow “well-groomed beards.” This decision, announced by owner Hal Steinbrenner, represents a momentous change in the franchise’s culture, which has long prioritized a clean-cut image and strict adherence to standards established
The healthcare landscape in the United States is replete with complexities, and UnitedHealthcare, as a major player in the industry, finds itself embroiled in a series of controversies that highlight both operational shortcomings and regulatory scrutiny. This prominent insurance giant is under investigation for questionable Medicare billing practices, is exploring employee buyouts amid potential layoffs,
Bluebird Bio’s transition from a leading biotech innovator to a mere footnote in the industry illustrates the unpredictable nature of biotechnology investments and the challenges that surround gene therapies. Once heralded for their ambitious gene-modifying treatments, the company has undergone a rapid decline, culminating in a recent sale to private equity firms Carlyle and SK
Rivian Automotive, a prominent player in the electric vehicle (EV) market, recently announced a significant milestone by exceeding Wall Street’s expectations for its fourth-quarter earnings. Most notably, Rivian achieved its first gross quarterly profit—an essential benchmark that investors have been vigilantly monitoring. The company’s gross profit for this period reached an impressive $170 million, a
Forever 21, once a delightfully vibrant player in the fast fashion scene, is now standing precariously on the brink of financial collapse. According to insider sources, the retailer has recently engaged in discussions with liquidators, indicating its precarious situation as it contemplates a potential second bankruptcy filing. This bleak development comes in the wake of
In an ambitious move that combines the might of a sporting giant with the sleekness of a contemporary shapewear brand, Nike has announced a partnership with Kim Kardashian’s Skims. This collaboration, branded NikeSKIMS, aims to carve a niche in the women’s activewear market, a sector that has seen explosive growth, particularly with competitors like Lululemon,
Shares of Roku experienced a noteworthy uptick, climbing over 10% after the company released its latest earnings report, which surpassed Wall Street’s expectations. This development marks a significant milestone as Roku’s stock reached a new 52-week high, signaling robust confidence in the company’s direction. An interview with CEO Anthony Wood on CNBC’s “Squawk Box” provided
Moderna, the biotech company that first captured global attention with its groundbreaking COVID-19 vaccine, reported its fourth-quarter earnings for 2024, showcasing a paradox of higher revenue but substantial losses. As the pandemic-driven boom subsides, Moderna finds itself in a critical phase of recalibrating its strategies while dealing with a market that no longer guarantees the